// IP Marketing video - START// IP Marketing video - END

Drugs giant Novartis posts $2.08 billion Q4 net profit

Drugs giant Novartis posts $2.08 billion Q4 net profit

PanARMENIAN.Net - Swiss drug maker Novartis AG has reported a fourth-quarter net profit of $2.08 billion, AP said.

The result is 72 percent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million after ending its clinical study into wider uses of the hypertension drug Tekturna.

Novartis said Wednesday, January 23 that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.

The company also said that long-time chairman and former chief executive Daniel Vasella will leave the board at the next shareholders' meeting at the end of February.

 Top stories
Armenia's foreign debt amounts to $4.3 billion as of March 2017, while that of the central bank totaled $517.9 million.
According to Vardanyan, IDeA and its partners and donors have since 2007 invested more than $550 million in various projects in Armenia.
75.8 million kWh of Armenian electricity have been shipped to the Georgian market in the first quarter of 2017.
The government has made a decision to allocate to Sastex the building of the former regional hospital and the adjacent areas.
Partner news